VentriPoint Diagnostics Ltd V.VPT

Alternate Symbol(s): VPTDF

Healthcare Medical Devices

Ventripoint Diagnostics Ltd. is a Canada-based medical device company. It is engaged in the development and commercialization of diagnostic tools to monitor patients with heart disease. It develops a suite of applications for all heart diseases and imaging modalities, including congenital heart disease, pregnancy, pulmonary hypertension, COVID-19, technically difficult imaging and cardiotoxicity in oncology patients. It provides application of artificial intelligence to echocardiography. Its flagship product, Ventripoint Medical System (VMS+), enhances echocardiography to deliver cMRI levels of accuracy for volumetric measurements and ejection fractions for all four chambers of the heart. It has developed a solution that transforms cardiac care through its 3D ECHO and MRI software. VMS products are powered by its proprietary Knowledge Based Reconstruction technology, which is the result of a decade of development and provides accurate volumetric cardiac measurements equivalent to MRI.

TSXV:VPT - Post by User

VentriPoint Diagnostics Ltd > EuropeV4.0 at any time!🚀 Sales Mayo Clinic?Insiders know!😎

<< Previous

Bullboard Posts

Next >>

Post by jopatcloon Oct 17, 2024 11:33am

71 Views

Post# 36270014

EuropeV4.0 at any time!🚀 Sales Mayo Clinic?Insiders know!😎

GranhamB the vulture Remember good comment @cardinal When the biggest in the world buy, everyone buys...
& and the photo of Hugh and company on the tiles in the lobby of a building. Which was geo located to be the Mayo Clinic.
Remenber! Where has Hugh been lately Hugh in London maybe news Collaborations or Partnerships ? Very excited to have next messages from Dear friends of Dr. Adams the visionary with Ventripoint. (Sales or FDA V4.0) its going up Reminder of July 5, 2023 Ventripoint Diagnostics Makes Significant Sale to the Largest Heart Center in Germany (July 4 = low 0.13 and July 24 = high 0.325 ) FDA V4.0 and Sales at any time now Insiders know!

Working in the US midwest with Strategic Sales Manager Scott Hammerling this past week provided an excellent opportunity to meet with cardiologists and sonographers to discuss how VMS+ can integrate within their clinical workflows. We received positive feedback on the accuracy of RV measurements and the potential to achieve better patient compliance with scheduled studies.